Endometrial Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who are female
- People aged between 50 and 80 years old
- People who are willing to take part in the study and sign a consent form agreeing to participate
- People who are post-menopausal (meaning their periods have permanently stopped)
Who may not be able to join:
- People who have previously had their uterus (womb) removed through surgery
- People who are currently using hormone replacement therapy (HRT)
- People who are currently taking medications that suppress or weaken the immune system
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Antonella De Luca, IRCCS I.N.T. "G. Pascale"
Phone: 08117770603
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Creation and Testing of a Metabolomic Signature for Endometrial Carcinoma Screening; Evaluation of the Ability of the Metabolomic Signature to Discriminate Between Neoplasms of Different Histological Origins; Validation of the Developed Model in a Real-World Clinical Setting
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.